Johnson & Johnson vaccine gets emergency use authorization in Bangladesh

471

DHAKA, June 15, 2021 (BSS) – The Directorate General of Drug Administration (DGDA) today approved emergency use of Johnson & Johnson’s Covid-19 vaccine “Janssen” in the country.

The regulator has given Emergency Use Authorization ( EUA) after all necessary examinations by the committee, a press release of DGDA said.

According to the DGDA, Johnson & Johnson vaccine is the sixth vaccine to be given the Emergency Use Authorization (EUA).

On June 3, Directorate General of Drug Administration (DGDA) approved Chinese Covid-19 vaccine “CoronaVac”, manufactured by Sinovac Life Sciences Company Limited.

On May 27, the Directorate General of Drug Administration (DGDA) approved emergency use of Pfizer mRNA Covid-19 vaccine in the country.

Bangladesh has so far approved six COVID-19 vaccines to control the deadly disease. These vaccines are Johnson & Johnson, “CoronaVac”, manufactured by Sinovac Life Sciences Company Limited, Pfizer mRNA Covid-19 vaccine, Covishield produced by Serum Institute of India; Sputnik V manufactured by Generium Joint Stock Company of Russia; and Sinopharm produced by Beijing Institute of Biological Products Co Ltd of China.